Target intelligence / Profile preview

RNA, U6 small nuclear 332, pseudogene (RNU6-332P)

Target
RNU6-332P
Molecular classification
Other, Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 332, pseudogene (RNU6-332P) is a *pseudogene* related to the U6 small nuclear RNA (snRNA) gene family[2][5]. U6 snRNA plays a fundamental role in the spliceosome as a noncoding RNA involved in the excision of introns from pre-mRNA in the nucleus of eukaryotic cells[1][3]. However, RNU6-332P itself is annotated as a pseudogene, meaning it is a nonfunctional copy that does not encode functional RNA and is not believed to have direct biological activity, enzymatic function, or therapeutic relevance[2][5]. Like other pseudogenes, it may reflect genomic duplication events or vestiges of evolutionary gene families but is generally not transcribed into a functional molecule. **Additional context:** - Not a therapeutic target: Pseudogenes like RNU6-332P do not encode active products and are not targeted by approved medications, nor do they have known interacting drugs, biomarker status, or documented roles in disease or safety profiles. - Potential confusion: Functional U6 snRNA (non-pseudogene) is essential for RNA splicing, but the pseudogene variant RNU6-332P has no such known functional or therapeutic roles[1][3][2]. - Common issue: Many U6 pseudogenes exist in the human genome due to the evolutionary importance and high copy number of U6-type sequences, but they rarely retain function[1][5]. **Summary for structuring:** RNU6-332P is a non-functional pseudogene of the U6 small nuclear RNA gene family. It is not a protein, enzyme, receptor, transcription factor, or otherwise considered a molecular target. No drugs, disease roles, or biomarkers are associated, and its only significance is as a genomic sequence.

Other names
RNU6-332PU6 snRNA pseudogene 332U6 small nuclear RNA pseudogene 332

Beyond the preview

Go deeper on RNA, U6 small nuclear 332, pseudogene (RNU6-332P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 332, pseudogene (RNU6-332P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call